Canada’s biotech boom won’t matter if the growth happens somewhere else

Companies and investors need confidence that discoveries made in Canada can continue to be developed and commercialized here.

Health Minister Marjorie Michel. Canada already has a significant advantage in biotechnology and life sciences. The question is whether we are able to fully capitalize on it, writes Wendy Zatylny. The Hill Times photograph by Andrew Meade

Opinion

BY WENDY ZATYLNY

September 16, 2026

Canada’s next generation of economic growth may not come from the industries on which we have traditionally relied.

To keep reading, subscribe and become a political insider.

Only $7.76 a week for an annual subscription.

Enjoy unlimited website access and the digital newspaper.

Cancel anytime.

Already a Subscriber?

Get Weekend Point of View Newsletter

A round up of the past weekâ€™s opinion writers and columnists on Saturdays and Sundays.

By entering your email address you consent to receive email from The Hill Times containing news, analysis, updates and offers. You may unsubscribe at any time. See our privacy policy

FOLLOW THE HILL TIMES: